MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Clinical features"

  • MDS Virtual Congress 2020

    Plasma biomarker quantification in SCA3 using the Neurology 4-PLEX A kit and the Simoa technology

    H. Garcia-Moreno, G. Thomas-Black, A. Heslegrave, H. Zetterberg, P. Giunti (London, United Kingdom)

    Objective: We present the results of plasma biomarker quantification in a cohort of spinocerebellar ataxia type-3 (SCA3) carriers using a Simoa assay. Background: Development of…
  • MDS Virtual Congress 2020

    Impulsivity and Compulsivity in Cerebellar Ataxias

    N. Amokrane, A. Viswanathan, S. Freedman, C. Yang, S. Kuo, C. Lin (New York, NY, USA)

    Objective: To elucidate the role of human cerebellum in the reward processing system, of which a new cerebellar circuitry was recently identified in mice [1].…
  • MDS Virtual Congress 2020

    Axial myoclonus and cerebellar ataxia in a patient with mutation in ADCK3

    M. Gultekin (Kayseri, Turkey)

    Objective: We herein report a 20 years old female, who presented with axial myoclonus, dysarthria and gait ataxia. Background: Autosomal recessive  ataxias are a group…
  • MDS Virtual Congress 2020

    Measurement of speech as a biomarker of neurodegenerative disease using acoustic profiles and machine learning

    B. Schultz, Z.. Joukhader, U. Nattala, G. Noffs, J. Chan, S. Rojas-Azaocar, H. Reece, M. Magee, M. Delatycki, L. Corben, A. Walt, A. Vogel (Melbourne, Australia)

    Objective: To examine the utility of speech biometrics for describing and delineating neurodegenerative diseases using acoustic measures and machine learning procedures. Background: Progressive neurological disorders…
  • MDS Virtual Congress 2020

    Characterization of ataxia in Sjogren’s syndrome

    C. Jaques, M. de Moraes, E. Silva, A. Coimbra Neto, G. Franklin, A. Martinez, S. Camargos, F. Cardoso, M. França Junior, A. Nucci, H. Teive, J. Pedroso, O. Barsottini (São Paulo, Brazil)

    Objective: This study aimed to characterize the pattern of ataxia in Sjogren’s syndrome and also to describe cerebellar ataxia and cerebellar atrophy in some of…
  • MDS Virtual Congress 2020

    The Phenotypical Presentation of SCA8 in Taiwan

    Y.C Liaw, H.L Chiang (Taipei City, Taiwan)

    Objective: ​​​​​We described the clinical features and phenotypic presentation of 40 patients who was diagnosed with spinocerebellar ataxia type 8 (SCA8) in a single tertiary…
  • MDS Virtual Congress 2020

    Spinocerebellar Ataxia Type 3 Presenting with Motor Neuron Disease

    C. Jaques, J. Pedroso, A. Rocha, W. Pinto, A. Oliveira, O. Barsottini (São Paulo, Brazil)

    Objective: Spinocerebellar ataxia type 3 (SCA3) is associated with a wide spectrum of clinical manifestations, including peripheral neuropathy and amyotrophy, in addition to other motor…
  • MDS Virtual Congress 2020

    Speech biometrics can predict cerebellar dysfunction in multiple sclerosis

    A. Vogel, G. Noffs, F. Boonstra, T. Perera, S. Kolbe, J. Stankovich, H. Butzkueven, A. Evans, A. der Walt (Melbourne, Australia)

    Objective: To objectively describe cerebellar mediated speech function using a multiparameter index that reflects pathology and quality of life in MS. Background: Cerebellar function plays…
  • MDS Virtual Congress 2020

    The genetic study of autosomal dominant spinocerebellar ataxia in Kazakhstan

    R. Kaiyrzhanov, N. Zharkinbekova, A. Aitkulova, J. Jarmukhanov, V. Akhmetzhanov, A. Taskynbayeva, C. Shashkin (Shymkent, Kazakhstan)

    Objective: To perform the genetic study of autosomal dominant spinocerebellar ataxia (ADSCA) cases from Kazakhstan. Background: Spinocerebellar ataxias (SCAs) is a large group of hereditary…
  • MDS Virtual Congress 2020

    SYNGAP1-related intellectual disability with ataxia and late onset of epileptic seizures

    N. Gogatishvili, T. Tkemaladze, V. Skrahina, S. Kasradze, A. Rolfs (Tbilisi, Georgia)

    Objective: To characterize seizures in a patient with SYNGAP1 mutation and the efficacy of antiepileptic drugs (AEDs). Background: SYNGAP1-related intellectual disability is characterized by developmental…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 27
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley